The Types segmentation classifies software deployment models into Cloud‑based, On‑premise, and Hybrid solutions. Cloud‑based platforms, contributing approximately 55 % of market value, are favored for their scalability, lower upfront capital expenditure, and ease of updates, enabling laboratories to process large datasets without extensive local infrastructure. On‑premise solutions, accounting for about 30 % of revenue, remain critical for organizations with stringent data‑privacy requirements or limited internet bandwidth, offering full control over hardware and software environments. The Hybrid model, representing the remaining 15 %, combines cloud flexibility with on‑site security, allowing firms to allocate sensitive workloads locally while leveraging cloud resources for computationally intensive analyses. Each type influences adoption patterns and pricing structures, thereby affecting the overall market dynamics within the Blood Functional Analysis Software segmentation.